TTravel Pass officials have been asked to add the new COVID vaccine, Covovax, to the list of approved shots for entry into T&T.
Health Minister Terrence Deyalsingh announced this on Saturday, one day after the World Health Organization said it listed the vaccine for emergency use.
The shot is produced by the Serum Institute of India under license by Novovax.
It is part of the COVAX facility portfolio and, according to WHO, gives a much-needed boost to ongoing vaccination efforts for lower-income countries.
WHO also says, “Covovax was assessed under the WHO EUL procedure based on the review of data on quality, safety and efficacy, a risk management plan, programmatic suitability, and manufacturing site inspections carried out by the Drugs Controller General of India. The Technical Advisory Group for Emergency Use Listing (TAG-EUL), convened by WHO and made up of experts from around the world, has determined that the vaccine meets WHO standards for protection against COVID-19, that the benefit of the vaccine far outweighs any risks, and that the vaccine can be used globally.”